Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Icell Kealex Therapeutics

PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of T-cell virus. The specializes in developing a T-cell engager-armed virus for the treatment of solid tumors.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
  • Houston, TX
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Icell Kealex Therapeutics’s full profile, request a free trial.

Icell Kealex Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 02-Mar-2016 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Icell Kealex Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0